These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16253867)

  • 1. Unusual suspect for antipsychotic-induced diabetes.
    O'Neill MF
    Drug Discov Today; 2005 Oct; 10(20):1338. PubMed ID: 16253867
    [No Abstract]   [Full Text] [Related]  

  • 2. Study focuses in on potential cause of antipsychotic-induced diabetes.
    O'Neill MF
    Drug News Perspect; 2005 Oct; 18(8):481-2. PubMed ID: 16391716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is olanzapine a brain-sparing medication?
    Joober R; Schmitz N; Malla A; Sengupta S; Karma S
    Arch Gen Psychiatry; 2006 Nov; 63(11):1292. PubMed ID: 17088510
    [No Abstract]   [Full Text] [Related]  

  • 4. Antipsychotic drugs and schizophrenia.
    Duan N; Kraemer HC; Mintz J
    N Engl J Med; 2006 Jan; 354(3):298-300; author reply 298-300. PubMed ID: 16422019
    [No Abstract]   [Full Text] [Related]  

  • 5. [Olanzapine].
    Wittköpper K; El-Armouche A; Eschenhagen T
    Dtsch Med Wochenschr; 2008 Sep; 133(39):1958-62. PubMed ID: 18798132
    [No Abstract]   [Full Text] [Related]  

  • 6. Research on adverse drug events. I. Muscarinic M3 receptor binding affinity could predict the risk of antipsychotics to induce type 2 diabetes.
    Silvestre JS; Prous J
    Methods Find Exp Clin Pharmacol; 2005 Jun; 27(5):289-304. PubMed ID: 16082416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipsychotic drugs: the weight problem.
    Harv Ment Health Lett; 2000 Dec; 17(6):6-8. PubMed ID: 11114878
    [No Abstract]   [Full Text] [Related]  

  • 8. Potential for detection bias in the association between olanzapine and diabetes.
    Compton MT; Hill HA
    J Clin Psychiatry; 2004 Feb; 65(2):274; author reply 275. PubMed ID: 15003085
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term treatment with atypical antipsychotics and risk of weight gain.
    Stip E; Anselmo K; Wolfe M; Lessard C; Landry P
    Drug Saf; 2006; 29(6):550-2; author reply 552. PubMed ID: 16752937
    [No Abstract]   [Full Text] [Related]  

  • 10. Polymorphisms of the histamine receptor (H1HR) gene are not associated with olanzapine-induced weight gain.
    Godlewska BR; Olajossy-Hilkesberger L; Olajossy M; Limon J; Landowski J
    J Clin Psychopharmacol; 2013 Jun; 33(3):436-7. PubMed ID: 23609395
    [No Abstract]   [Full Text] [Related]  

  • 11. A regional comparison of developing diabetes among VA patients exposed to typical and atypical antipsychotics relative to corticosteroids and proton pump inhibitors.
    Barnett M; Argo T; Alexander B; Perry P
    Ann Clin Psychiatry; 2006; 18(1):1-7. PubMed ID: 16517447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Olanzapine use in a patient with schizophrenia and the risk of diabetes.
    Folnegović-Smalc V; Jukić V; Kozumplik O; Mimica N; Uzun S
    Eur Psychiatry; 2004 Feb; 19(1):62-4. PubMed ID: 14969784
    [No Abstract]   [Full Text] [Related]  

  • 13. Olanzapine and weight gain.
    Isaac MB; Isaac MT
    Am J Psychiatry; 2005 Sep; 162(9):1764-5; author reply 1765. PubMed ID: 16135655
    [No Abstract]   [Full Text] [Related]  

  • 14. Bofu-tsusho-san effectively attenuates the weight gain observed after receiving olanzapine.
    Yamamoto N; Inada T
    Psychiatry Clin Neurosci; 2008 Dec; 62(6):747. PubMed ID: 19068015
    [No Abstract]   [Full Text] [Related]  

  • 15. The implications of weight changes with antipsychotic treatment.
    Sussman N
    J Clin Psychopharmacol; 2003 Jun; 23(3 Suppl 1):S21-6. PubMed ID: 12832946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schizophrenia, antipsychotics and metabolic disease.
    Reynolds GP
    J Psychopharmacol; 2007 Jun; 21(4):355-6. PubMed ID: 17656424
    [No Abstract]   [Full Text] [Related]  

  • 17. Diabetes resolution following discontinuation of a second-generation antipsychotic.
    Strassnig M; Awerbuck J; Ganguli R
    Clin Schizophr Relat Psychoses; 2013 Jan; 6(4):202-3. PubMed ID: 23302450
    [No Abstract]   [Full Text] [Related]  

  • 18. Considerations regarding the use of metformin with olanzapine.
    Alamiri B
    Am J Psychiatry; 2008 Sep; 165(9):1205-6; author reply 1207. PubMed ID: 18765498
    [No Abstract]   [Full Text] [Related]  

  • 19. Predictors of antipsychotic-induced weight gain in first-episode psychosis: conclusions from a randomized, double-blind, controlled prospective study of olanzapine, risperidone, and haloperidol.
    Saddichha S; Ameen S; Akhtar S
    J Clin Psychopharmacol; 2008 Feb; 28(1):27-31. PubMed ID: 18204337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risperidone alternative for a schizophrenic patient with olanzapine-exacerbated diabetic mellitus.
    Wu PL; Lane HY; Su KP
    Psychiatry Clin Neurosci; 2006 Feb; 60(1):115-6. PubMed ID: 16472369
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.